Trial reportEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2025
Impact of 3-dimensional myofascial release on tumor necrosis factor (TNF) alpha biomarker in nonspecific low back pain: a randomised controlled trial.
Trial report in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundNon- specific low back pain (NSLBP) is a common musculoskeletal disorder that leads to disability. Its development has been associated with inflammatory responses including cytokines such as TNF-α. Various management approaches, including manual therapy and exercise therapy to treat NSLBP. Manual therapy including myofascial release (MFR) has shown to reduce the pain and improve soft tissue flexibility and mobility. It was therefore hypothesized that three-dimensional MFR (3D-MFR) would reduce TNF-α levels in individuals with NSLBP. This present study aimed to investigate the effect of three-dimensional myofascial release (3D-MFR) on inflammation as indicated by TNF-α level, as well as on pain intensity and quality of life in individuals with NSLBP. METHODOLOGY: A double-blinded randomized controlled trial was conducted over a 6 month period in the tertiary care centre. 40 participants aged 18-50 years with a clinical diagnosis of nonspecific low back pain. Participants were randomly allocated into two groups using a computer-generated randomization sequence with allocation concealed through sealed opaque envelopes, one receiving 3D-MFR and the other a sham group intervention, both over 4 weeks. Outcomes included concentration of TNF-α level (in blood and urine), Visual Analogue Scale (VAS) scores for pain intensity and Modified Oswestry Disability Index (MODI) scores for quality of life assessed before and after the intervention.
resultsPost-intervention, the blood TNF-α in 3D-MFR group (p = 0.001; CI- LL = 5.62, UL = 14.69) compared to the Sham group (p = 0.85; CI- LL = 9.97, UL = 20.09) and urine TNF-α levels in 3D-MFR group (p = 0.003; CI- LL = 0.61, UL = 1.33) compared to the Sham group (p = 0.744; CI- LL = 1.36, UL = 2.63). VAS scores in 3D- MFR group (p < 0.001; CI- LL = 2.2, UL = 3.39) versus the Sham group (p = 0.001; CI- LL = 4.06, UL = 5.31), MODI scores for 3D-MFR group (p < 0.001; CI- LL = 23.69, UL = 34.09) compared to the Sham group (p < 0.001; CI- LL = 37.65, UL = 49.4).
conclusionThis study concludes that three-dimensional myofascial release effectively reduces inflammation and pain intensity, while improving quality of life in individuals with Non-specific low back pain. These findings support the integration of fascia-based manual therapy into multidisciplinary approaches for managing low back pain.
Indexed as
Identifiers
40853451What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.